Biocon Ltd
₹365.70
(-0.77)%
Thu, 05 Feb 2026, 08:50 am
Health Technology
Pharmaceuticals: Major
24.5K1 Day
0 (0%)
No Result Found
Summary
Market Cap
59754.77
Net Profit
1429.40
P/B
1.89
Sector P/E
32.41
P/E
40.43
EV/EBITDA
12.35
Debt/Equity (Industry)
0.28
Interest Cover (Industry)
4.34
ROCE (Industry)
8.45
RONW (Industry)
6.56
ROE
6.90
ROCE
6.86
Debt/Equity
0.84
EPS (TTM)
2.89
Dividend Yield
0.10
Book Value
233.84
Interest Cover
3.10
Analysis
all
- Cash flow for Biocon is expected to increase by more than 50% in 2 years time.
- Biocon's earnings are expected to grow significantly at over 20% yearly.
- Biocon's earnings growth is expected to exceed the India market average.
- Biocon's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Biocon's earnings are expected to exceed the low risk growth rate next year.
- Biocon is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Biocon's dividends as it is not paying a notable one for India.
- No need to calculate the sustainability of Biocon's dividends in 3 years as they are not expected to pay a notable one for India.
- Biocon is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Biocon's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 44.91 | 54.45 | 54.45 | 60.64 | 60.64 |
| FII | 7.14 | 6.61 | 6.04 | 5.66 | 5.66 |
| DII | 24.16 | 22.10 | 22.82 | 15.72 | 15.37 |
| Public | 23.79 | 16.83 | 16.68 | 17.97 | 18.34 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 454.73 | 414.83 | 390.82 | 374.93 | 350.92 | 335.03 | 295.13 |
| Fibonacci | 414.83 | 399.59 | 390.18 | 374.93 | 359.69 | 350.28 | 335.03 |
| Camarilla | 377.77 | 374.12 | 370.46 | 374.93 | 363.14 | 359.49 | 355.83 |
Pivots Level: Classic
R3
+79.80
454.73
R2
+39.90
414.83
R1
+15.88
390.82
S1
-24.02
350.92
S2
-39.90
335.03
S3
-79.80
295.13
Moving Average
Period
Value
10-EMA
369.09
20-EMA
372.46
30-EMA
375.43
50-EMA
378.13
100-EMA
376.63
200-EMA
368.76
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 06 Dec 2025 | egm | ||
| 11 Nov 2025 | board-meetings | Quarterly Results | |
| 08 May 2025 | dividend | ₹0.50 Dividend /Share | 04 Jul 2025 |
| 08 May 2025 | agm | ||
| 16 May 2024 | agm | ||
| 16 May 2024 | dividend | ₹0.50 Dividend /Share | 05 Jul 2024 |
| 23 May 2023 | dividend | ₹1.50 Dividend /Share | 07 Jul 2023 |
| 23 May 2023 | agm | ||
| 28 Apr 2022 | agm | ||
| 28 Apr 2022 | dividend | ₹0.50 Dividend /Share | 01 Jul 2022 |
Peer Comparison
Biocon Ltd
Divis Laboratories Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Cipla Ltd
About Biocon Ltd
Biocon is engaged in the manufacture of biotechnology products and research services.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1978
Headquarters
CEO
Kiran Mazumdar Shaw
Employees
Contact
Website
http://www.biocon.com
co.secretary@biocon.com
Phone
91-80-28082808
Location
20th KM Hosur Road Hebbagodi, Electronic City P O, Bangalore, Karnataka, 560100
biocon ltd History
| Year | History |
|---|---|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
| 2025 |
|
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800